• 1
    Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010; 149: 3613.
  • 2
    Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 12645.
  • 3
    Reibaldi M, Cardascia N, Longo A et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2010; 149: 30715.
  • 4
    Folk JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 1984; 102: 1299302.
  • 5
    Chuang EL, Sharp DM, Fitzke FW, Kemp CM, Holden AL, Bird AC. Retinal dysfunction in central serous retinopathy. Eye 1987; 1: 1205.
  • 6
    Miyake Y, Shiroyama N, Ota I, Horiguchi M. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988; 106: 54650.
  • 7
    Nagata M, Honda Y. Macular ERG in central serous retinopathy. Jpn J Ophthalmol 1971; 15: 916.
  • 8
    Toonen F, Remky A, Janssen V, Wolf S, Reim M. Microperimetry in patients with central serous retinopathy. Ger J Ophthalmol 1995; 4: 31114.
  • 9
    Ozdemir H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O. Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye 2008; 22: 2048.
  • 10
    Frisen L, Frisen M. Micropsia and visual acuity in macular edema: a study of the neuro-retinal basis of visual acuity. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1979; 2: 6977.
  • 11
    Piccolino FC, de la Longrais RR, Ravera G et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005; 139: 8799.
  • 12
    Fletcher DC, Schuchard RA. Visual function in patient's with choroirdal neovascularization resulting from age related macular degeneration: the importance of looking beyond visual acuity. Optom Vis Sci 2006; 83: 17889.
  • 13
    Springer C, Bültmann S, Völcker HE, Rohrschneider K. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 2005; 112: 84854.
  • 14
    Rohrschneider K, Springer C, Bültmann S, Völcker HE. Microperimetry-comparison between the micro perimeter 1 and scanning laser ophthalmoscope – fundus perimetry. Am J Ophthalmol 2005; 139: 12534.
  • 15
    Squirrell DM, Mawer NP, Mody CH, Brand CS. Visual outcome after intravitreal ranibizumab for wet age-related macular degeneration: a comparison between best-corrected visual acuity and microperimetry. Retina 2010; 30: 43642.
  • 16
    Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M, Takatsuna Y. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond) 2006; 20: 8059.
  • 17
    Richter-Mueksch S, Ve'csei-Marlovits PV, Sacu SG, Kiss CG, Weingessel B, Schmidt-Erfurth U. Functional macular mapping in patients with vitreomacular pathologic features before and after surgery. Am J Ophthalmol 2007; 144: 2331.
  • 18
    Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report. Arch Ophthalmol 1999; 117: 132945.
  • 19
    Ojima Y, Tsujikawa A, Hangai M et al. Retinal sensitivity measured with the micro perimeter 1 year after resolution of central serous chorioretinopathy. Am J Ophthalmol 2008; 146: 7784.
  • 20
    Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O. Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 2011; 151: 3039.
  • 21
    Fujita K, Yuzawa M, Mori R. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 2011; 31: 7728.
  • 22
    Chen FK, Patel PJ, Xing W et al. Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 2009; 50: 346472.